You have 1 action to finish to complete your account. Craft your experience by picking your interest on the Personalisation Page
Type 2 Inflammation

ADVENT at ISDS 2023: Navigating Recent Scientific Advances in Atopic Dermatitis: Skin Barrier Dysfunction, Dysbiosis, and Itch

Highlights from the ADVENT symposium at the Inflammatory Skin Disease Summit (ISDS) 2023 exploring the role of type 2 inflammation in atopic dermatitis.

Lisa Beck
Robert Bissonnette
Gil  Yosipovitch
MD
Lisa Beck +2 more
Past event
16November2023
Location
Aula der Wissenschaften
Wollzeile 27a A-1010 Vienna Austria

Learning objectives

  • Review the latest evidence on how type 2 inflammation drives skin barrier dysfunction in AD
  • Discuss the evidence illustrating how type 2 inflammation affects the skin microbiome in AD
  • Explore the role of type 2 inflammation in neuroimmune axis dysregulation in AD

Description

At the ADVENT symposium at the 2023 Inflammatory Skin Disease Summit entitled “Navigating Recent Scientific Advances in Atopic Dermatitis: Skin Barrier Dysfunction, Dysbiosis, and Itch”, experts Lisa A. Beck, MD (University of Rochester Medical Center, USA); Robert Bissonnette, MD (Innovaderm Research Inc., Canada); and Gil Yosipovitch, MD (University of Miami, USA) discussed the latest advances in understanding how type 2 inflammation drives skin barrier dysfunction, dysbiosis and itch in atopic dermatitis (AD).

 

Location
Aula der Wissenschaften
Wollzeile 27a A-1010 Vienna Austria
MAT-GLB-2303613 v1 11/2023

Speakers